SGLT2 Inhibitors As First Line Therapy to Prevent Renal Decline in Type 2 Diabetes

This study is testing whether SGLT2 inhibitors (a class of diabetes pill that also protects the kidneys and heart) can be used as a first-line treatment instead of metformin in people newly diagnosed with type 2 diabetes, to prevent kidney damage from the start. **You may be eligible if...** - You have been diagnosed with type 2 diabetes - You are 18 years or older - Your BMI is above 18.5 - You are either not on any diabetes medication yet, or you are only on metformin - Your kidney function is adequate (eGFR ≥45) **You may NOT be eligible if...** - You urgently need intensive blood sugar control - You have established coronary artery disease (heart attack, stents, bypass surgery) or heart failure - You have a known reason you cannot take metformin or SGLT2 inhibitors - Your kidney function is below the required threshold Talk to your doctor to see if this trial is right for you.